Diabetes complications

Epidemiology of major amputation following diabetic foot ulcer: Insights from recent nationwide data in the french national health registry (SNDS)

Diabetes MetabPublished Retrospective nationwide cohort study

Authors' conclusion

This is the first national study of the care pathways followed by people with DFU. Failures in the care pathway, precariousness and several comorbidities were identified, with an impact on the MA risk.

Study context

Population
People living with diabetes and incident DFU, France, 2018
Participants
133,791 people
Outcome
Occurrence of major lower limb amputation (MA)
Follow-up
Within one year
Methodological detailsFrench National Health Data System (SNDS)
  • French National Health Data System (SNDS)

Main finding

As reported in the abstract

Major lower limb amputation · during follow-up

MA performed

4,733

3.5 %

Observational data: associations, not effects.

Further findings

Factors associated with MA

Male sex, HR [95% CI]
1.92 [1.78;2.08]
Lower limb arteriopathy, HR [95% CI]
10.16 [9.36;11.03]
Psychiatric disease, HR [95% CI]
1.10 [1.01;1.20]
End-stage renal disease, HR [95% CI]
2.12 [1.93;2.33]

Care pathway and MA (lower MA rates with more visits)

More general practitioner visits, HR [95% CI]
0.83 [0.75-0.91]
More private nurse visits, HR [95% CI]
0.88 [0.81-0.95]
More diabetologist visits, HR [95% CI]
0.88 [0.81-0.95]

Deprivation and MA

Living in most disadvantaged municipalities (higher MA rate), HR [95% CI]
1.17[1.06-1.29]

People with MA included via out-of-hospital part of protocol, first hospital contact led to MA

Proportion of people with MA
16.4 %

Original publication

Epidemiology of major amputation following diabetic foot ulcer: Insights from recent nationwide data in the french national health registry (SNDS). Diabetes Metab. Published 13 January 2025. doi:10.1016/j.diabet.2025.101606

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.